HAYLEY NORTON: Open Payments
NPI 1346632031 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 18 payments from 10 companies in 2025. Trend: 2023 $63 · 2024 $272 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $190 |
| Daiichi Sankyo Inc. | 3 | $51 |
| Celgene Corporation | 2 | $42 |
| Aveo Pharmaceuticals, Inc. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $16 |
| SOBI, INC | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
| PharmaEssentia USA Corporation | 1 | $14 |
| pharmaand GmbH | 1 | $8 |
Products named: RYBREVANT, Enhertu, REBLOZYL, TECVAYLI, FOTIVDA, Fabhalta, DARZALEX, Trodelvy.
Industry payments across TX — which companies pay providers there.
